Why TRT Suppresses Natural Testosterone Production
To understand why HCG is used with TRT, you need to understand the hypothalamic-pituitary-gonadal (HPG) axis — the hormonal feedback loop that controls testosterone production.
Normally, the hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to release two key hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH signals the testes to produce testosterone, while FSH stimulates sperm production.
When you take exogenous (external) testosterone via TRT, your brain detects elevated testosterone and responds by reducing GnRH output. This causes LH and FSH to fall dramatically — often to near-undetectable levels. Without LH stimulation, the Leydig cells in the testes stop producing their own testosterone, and without FSH, sperm production (spermatogenesis) shuts down.
The result: testicular atrophy (the testes shrink), sperm production stops or dramatically decreases, and intratesticular testosterone (ITT) — the testosterone within the testes — falls to very low levels. This can cause infertility and physical changes that many men find uncomfortable or distressing.
What Is HCG?
Human chorionic gonadotropin (HCG) is a glycoprotein hormone naturally produced during pregnancy that has an almost identical molecular structure to LH. Because the LH receptor and HCG receptor are the same (or nearly identical) receptors, HCG can mimic LH's action on the testes.
When administered to men on TRT, HCG directly stimulates the Leydig cells in the testes to continue producing testosterone internally — preserving intratesticular testosterone levels, testicular size, and (in combination with FSH or other interventions) supporting sperm production.
Why Men Add HCG to Their TRT Protocol
1. Preserving Fertility
TRT causes azoospermia (no sperm in semen) in the majority of men within 3–6 months. For men who have not yet completed their families or who want to maintain the possibility of future fertility, this is a significant concern. HCG can largely maintain sperm production by keeping intratesticular testosterone levels high. However, HCG alone may not be sufficient for all men — some also require FSH (either as purified FSH or HMG) to fully support spermatogenesis.
For men who want to actively father children while on TRT, a fertility specialist should be involved in protocol design.
2. Preventing Testicular Atrophy
Testicular atrophy on TRT is common and can be quite pronounced — some men notice a 25–50% reduction in testicular volume over time. This is not just a cosmetic concern: smaller testes may also be associated with reduced intratesticular testosterone, which can affect libido, mood, and sexual function in ways that exogenous TRT doesn't fully replicate.
HCG effectively prevents testicular atrophy by maintaining LH stimulation of the testes. Many men report maintained or restored testicular size and a subjective improvement in "natural feel" of their sexual function.
3. Maintaining Intratesticular Testosterone
Even on TRT with normal serum testosterone levels, intratesticular testosterone (ITT) — which is much higher than serum testosterone under normal circumstances — falls dramatically. Some researchers and clinicians believe that low ITT, even with normal serum testosterone, may contribute to suboptimal symptom resolution in some men on TRT. HCG restores ITT by re-engaging the Leydig cells.
4. Supporting the Adrenal-Gonadal Steroid Pathway
The testes produce not just testosterone but also other hormones including DHEA, androstenedione, and pregnenolone — precursors and related steroids that contribute to overall hormonal balance. TRT suppresses this entire cascade. HCG, by keeping the Leydig cells active, helps maintain some of this broader steroidogenic output.
HCG Dosing Protocols
HCG for TRT support is typically dosed much lower than HCG used for fertility induction. Common protocols include:
- Low-dose concurrent protocol: 250–500 IU subcutaneously 2–3 times per week, taken alongside testosterone. This is the most commonly prescribed protocol for testicular preservation.
- Higher fertility-focused doses: 1,000–3,000 IU 2–3 times per week when actively trying to achieve pregnancy. Typically combined with FSH or HMG.
- PCT (post-cycle therapy) protocol: Higher doses used to restart endogenous production after stopping TRT — not standard for ongoing TRT co-administration.
HCG is self-administered as a subcutaneous injection (similar to insulin pens). It must be refrigerated and has a relatively short shelf life once reconstituted.
Kisspeptin and Enclomiphene as HCG Alternatives
For men who want to preserve fertility and function without starting TRT, or who prefer not to add injections to their protocol, two alternatives are increasingly used:
- Enclomiphene citrate: A selective estrogen receptor modulator (SERM) that blocks estrogen's feedback on the hypothalamus, causing GnRH → LH → testosterone to increase endogenously. It raises testosterone, preserves fertility, and avoids testicular suppression.
- Clomiphene citrate (Clomid): The racemic mixture of enclomiphene; similar mechanism but with mixed effects from its zuclomiphene component.
These options are discussed as alternatives to TRT in our TRT methods guide.
Potential Side Effects of HCG
HCG is generally well tolerated at low doses used for TRT support. Potential side effects include:
- Elevated estradiol: HCG stimulates the testes to produce testosterone, but also aromatase within the testes — converting testosterone to estradiol. Men with a tendency toward high estrogen may need closer estrogen monitoring and potentially an aromatase inhibitor.
- Mood changes: Some men report mood fluctuations, anxiety, or irritability with HCG. This may be related to estrogen changes.
- Injection site reactions: Mild bruising or discomfort at injection sites.
- Acne: Increased androgen activity can trigger breakouts in susceptible men.
- Water retention: Some men notice fluid retention, often related to elevated estradiol.
HCG Availability After FDA Reclassification
In 2020, the FDA reclassified HCG as a biological product and ended the practice of pharmacies compounding HCG under Section 503B of the Drug Quality and Security Act. This created significant access issues for men using HCG for TRT support. As a result, many TRT prescribers have shifted to FDA-approved urinary-derived HCG products (like Pregnyl or Novarel) or begun using kisspeptin, gonadorelin (GnRH analog), or enclomiphene as alternatives.
Gonadorelin — a synthetic GnRH agonist — is now commonly used as an HCG substitute in TRT protocols. Administered as a subcutaneous injection 2–3 times per week, it stimulates the pituitary to release LH and FSH naturally, effectively preserving testicular function. Your prescribing clinician will advise on availability and the best option for your situation.
Is HCG Right for You?
HCG (or gonadorelin) is a reasonable addition to a TRT protocol for men who:
- Want to preserve fertility during TRT
- Are concerned about testicular atrophy
- Report incomplete symptom resolution on TRT alone and may benefit from restored intratesticular testosterone
- Plan to stop TRT at some point and want to make that transition easier
It adds cost and complexity to a TRT protocol, so men who have completed their families and aren't concerned about testicular atrophy may not need it. The decision should be made collaboratively with your clinician based on your individual goals and clinical picture.
For more information on how testosterone therapy affects heart health and overall wellbeing, see our guide on testosterone and cardiovascular health in men.
The Endocrine Society's hypogonadism guidelines address fertility preservation as an important consideration in TRT management.
Ready to take control of your health?
Connect with a licensed clinician from home. No waiting rooms, no hassle.
Start Free Consultation